Morpholine, 4-(2-chloroethyl)-, hydrochloride (1:1) → 1-{3-{Bis[4-(methoxymethoxy)phenyl]methyl}-1-(2-morpholinoethyl)indol-2-ylcarbonyl}-4-(2-chlorophenyl)-piperazine

HRID 442850Notes

Reaction equation

HRID 442850 reaction equation
[CH3:1][O:2][CH2:3][O:4][C:5]1[CH:10]=[CH:9][C:8]([CH:11]([C:36]2[CH:41]=[CH:40][C:39]([O:42][CH2:43][O:44][CH3:45])=[CH:38][CH:37]=2)[C:12]2[C:20]3[C:15](=[CH:16][CH:17]=[CH:18][CH:19]=3)[NH:14][C:13]=2[C:21]([N:23]2[CH2:28][CH2:27][N:26]([C:29]3[CH:34]=[CH:33][CH:32]=[CH:31][C:30]=3[Cl:35])[CH2:25][CH2:24]2)=[O:22])=[CH:7][CH:6]=1.Cl.[O:47]1[CH2:52][CH2:51][N:50]([CH2:53][CH2:54]Cl)[CH2:49][CH2:48]1>>[CH3:1][O:2][CH2:3][O:4][C:5]1[CH:6]=[CH:7][C:8]([CH:11]([C:36]2[CH:37]=[CH:38][C:39]([O:42][CH2:43][O:44][CH3:45])=[CH:40][CH:41]=2)[C:12]2[C:20]3[C:15](=[CH:16][CH:17]=[CH:18][CH:19]=3)[N:14]([CH2:54][CH2:53][N:50]3[CH2:51][CH2:52][O:47][CH2:48][CH2:49]3)[C:13]=2[C:21]([N:23]2[CH2:28][CH2:27][N:26]([C:29]3[CH:34]=[CH:33][CH:32]=[CH:31][C:30]=3[Cl:35])[CH2:25][CH2:24]2)=[O:22])=[CH:9][CH:10]=1

Participants

3

Reactant 2

HCID 77210Morpholine, 4-(2-chloroethyl)-, hydrochloride (1:1)HCID 158589011-{3-{Bis[4-(methoxymethoxy)phenyl]methyl}indol-2-ylcarbonyl}-4-(2-chlorophenyl)piperazine

Product 1

HCID 158589071-{3-{Bis[4-(methoxymethoxy)phenyl]methyl}-1-(2-morpholinoethyl)indol-2-ylcarbonyl}-4-(2-chlorophenyl)-piperazineYield 89%

Procedure

Substantially the same procedure as in Example 2 was repeated using Compound 1 (2.0 g, 3.19 mmol) obtained in Example 1 and 2-morpholinoethylchloride hydrochloride (600 mg, 3.19 mmol) to give 2.1 g (yield: 89%) of the title compound.

Sources & evidence

ORD record
ord-232ae2640bd3490cb47e7c02db9a9e98
Source dataset
uspto-grants-1999_04
Patent number
US05891902

Reaction notes

Loading…